Literature DB >> 17003462

Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.

Pauline E van Eeden1, Lisa B G Tee, Sherralee Lukehurst, Chooi-May Lai, Elizabeth P Rakoczy, Lyn D Beazley, Sarah A Dunlop.   

Abstract

PURPOSE: To investigate early retinal changes in a vascular endothelial growth factor (VEGF) transgenic mouse (tr029VEGF; rhodopsin promoter) with long-term damage that mimics nonproliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (PDR).
METHODS: Rhodopsin and VEGF expression was assessed up to postnatal day (P)28. Vascular and retinal changes were charted at P7 and P28 using sections and wholemounts stained with hematoxylin and eosin or isolectin IB4 Griffonia simplicifolia Samples were examined using light, fluorescence, and confocal microscopy.
RESULTS: Rhodopsin was detected at P5 and reached mature levels by P15; VEGF protein expression was transient, peaking at P10 to P15. In wild-type (wt) mice at P7, vessels had formed in the nerve fiber/retinal ganglion cell layer and showed a centroperipheral maturational gradient; some capillaries had formed a second bed on the vitread side of the inner nuclear layer (INL). By P28, the retinal vasculature had three mature capillary beds, the third abutting the sclerad aspect of the INL. In tr029VEGF mice, capillary bed formation was accelerated compared with that in wt, with abnormal vessels extending to the sclerad side of the INL by P7 and abnormally penetrating the photoreceptors by P28. Compared with P7, vascular lesions were more numerous at P28 when capillary dropout was also evident. At both stages, retinal layers were thinned most where abnormal vessel growth was greatest.
CONCLUSIONS: Concomitant damage to the vasculature and neural retina at early stages in tr029VEGF suggest that both tissues are affected, providing opportunities to examine early cellular events that lead to long-term disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003462     DOI: 10.1167/iovs.06-0251

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  16 in total

1.  Characterization of a mouse model of hyperglycemia and retinal neovascularization.

Authors:  Elizabeth P Rakoczy; Ireni S Ali Rahman; Nicolette Binz; Cai-Rui Li; Nermina N Vagaja; Marisa de Pinho; Chooi-May Lai
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

Review 2.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

Review 3.  Do photoreceptor cells cause the development of retinal vascular disease?

Authors:  Timothy S Kern
Journal:  Vision Res       Date:  2017-05-08       Impact factor: 1.886

4.  Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy.

Authors:  Stephen M Cronk; Molly R Kelly-Goss; H Clifton Ray; Thomas A Mendel; Kyle L Hoehn; Anthony C Bruce; Bijan K Dey; Alexander M Guendel; Daniel N Tavakol; Ira M Herman; Shayn M Peirce; Paul A Yates
Journal:  Stem Cells Transl Med       Date:  2015-03-13       Impact factor: 6.940

Review 5.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

Review 6.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

7.  Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.

Authors:  Polly A Quiram; Victor R Leverenz; Robert M Baker; Loan Dang; Frauk J Giblin; Michael T Trese
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

Review 8.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

Review 9.  Choosing preclinical study models of diabetic retinopathy: key problems for consideration.

Authors:  Xue-Song Mi; Ti-Fei Yuan; Yong Ding; Jing-Xiang Zhong; Kwok-Fai So
Journal:  Drug Des Devel Ther       Date:  2014-11-18       Impact factor: 4.162

Review 10.  Animal models of diabetic retinopathy: summary and comparison.

Authors:  Angela Ka Wai Lai; Amy C Y Lo
Journal:  J Diabetes Res       Date:  2013-10-27       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.